Open AccessDCIS with Microinvasion: Is It In Situ or Invasive Disease?
Author(s) -
Cosette D. Champion,
Yi Ren,
Samantha M. Thomas,
Oluwadamilola M. Fayanju,
Laura H. Rosenberger,
Rachel A. Greenup,
Carolyn S. Menendez,
E. Shelley Hwang,
Jennifer K. Plichta
Publication year - 2019
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-019-07556-9
Subject(s) - medicine , ductal carcinoma , lumpectomy , breast cancer , proportional hazards model , mastectomy , surgical oncology , oncology , gynecology , cancer
Ductal carcinoma in situ (DCIS) with microinvasion (DCISM) can be challenging in balancing the risks of overtreatment versus undertreatment. We compared DCISM, pure DCIS, and small volume (T1a) invasive ductal carcinoma (IDC) as related to histopathology, treatment patterns, and survival outcomes.